Elcepan 50mg/12.5mg/200mg Tablet is used in treating Parkinson's disease and its symptoms, including tremors, spasms, muscle stiffness and poor muscle control. Parkinson's disease is a disorder of the central nervous system that affects movement and locomotion.

Elcepan 50mg/12.5mg/200mg Tablet contains Carbidopa, Levodopa, and Entacapone, which work by maintaining the levels of dopamine in the brain. Thereby, it helps reduce symptoms of Parkinson's disease, such as tremors and stiffness.

The most common side effects of Elcepan 50mg/12.5mg/200mg Tablet are nausea, vomiting, loss of appetite, light-headedness, lowered blood pressure, confusion, and dyskinesia (uncontrolled/involuntary muscle movement). If the side effects persist or worsen, please consult your doctor.

If you are known to be allergic to any of the components in Elcepan 50mg/12.5mg/200mg Tablet, please tell your doctor. Consult your doctor if you are pregnant or breastfeeding. Keep your doctor informed about your medicines and health condition to rule out any side effects.

Elcepan 50mg/12.5mg/200mg Tablet is used in the treatment of Parkinson's disease. The detailed use of Elcepan 50mg/12.5mg/200mg Tablet is as follows:

• Treatment of Parkinson’s disease: Elcepan 50mg/12.5mg/200mg Tablet is used in the treatment of Parkinson's disease. It improves motor function and enhances mobility.

• Take Elcepan 50mg/12.5mg/200mg Tablet with or without food, or as advised by a doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow the medicine as a whole with a glass of water.
• Do not crush, break, or chew it.

• Elcepan 50mg/12.5mg/200mg Tablet is used to treat Parkinson’s disease. It contains Carbidopa, Levodopa, and Entacapone.
• Levodopa converts into dopamine in the brain, helping control movement and motor functions.
• Carbidopa prevents the breakdown of Levodopa in the bloodstream, ensuring more reaches the brain for effective symptom relief.
• Entacapone inhibits the enzyme COMT, prolonging the action of Levodopa and maintaining sustained dopamine levels.
• Elcepan 50mg/12.5mg/200mg Tablet reduces symptoms of Parkinson’s disease, including tremors, rigidity, stiffness, and slow movement.
• It enhances overall mobility and quality of life by improving the effectiveness and duration of Levodopa therapy.
• It supports overall neurological health, helping maintain a better quality of life for patients.

• Do not take Elcepan 50mg/12.5mg/200mg Tablet if you are allergic to any of its ingredients.
• The use of Elcepan 50mg/12.5mg/200mg Tablet is not recommended if a person takes monoamine oxidase inhibitors (MAOs) or antidepressant drugs like isocarboxazid, phenelzine, selegiline, and tranylcypromine because it can lead to a high blood pressure (hypertension) crisis.
• Do not stop taking Elcepan 50mg/12.5mg/200mg Tablet suddenly without talking to your doctor. It may result in a serious neuroleptic malignant syndrome (NMS) that causes fever, muscle cramps or stiffness, unusual body movements, fast heartbeat, sweating, change in thinking, and confusion.
• Tell your doctor if you have/had diabetes, a heart attack, a mental illness, stomach ulcers, heart disease, or have recently undergone a surgical procedure.
• Elcepan 50mg/12.5mg/200mg Tablet may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position, especially when you start taking Elcepan 50mg/12.5mg/200mg Tablet, so please get up gradually.
• Prolonged intake of Elcepan 50mg/12.5mg/200mg Tablet may lead to greater chances of neuropathy (nerve damage).
• Elcepan 50mg/12.5mg/200mg Tablet should be used with caution in patients with eye problems (narrow-angle glaucoma), irregular heartbeat (arrhythmia), gastrointestinal bleeding, and psychosis.
• Let your doctor know if you are taking any other medicines, including supplements and herbal products.